Haemonetics (STU:HAZ) Float Percentage Of Total Shares Outstanding: 73.76% (As of Jul. 09, 2026)


STU:HAZ Haemonetics Corp STU:HAZ
83 GF Score
Price €64.50
GF Value €74.31
! 4 Warning Signs
View Full Analysis

What is Haemonetics Float Percentage Of Total Shares Outstanding?

Haemonetics STU:HAZ -1.53% 83 Float Percentage Of Total Shares Outstanding is 73.76% as of Jul. 09, 2026. GuruFocus rates STU:HAZ with a GF Score™ of 83/100 and a GF Value™ of €74.31. The stock has 4 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Haemonetics's float shares is 33.52 Mil. Haemonetics's total shares outstanding is 45.45 Mil. Haemonetics's float percentage of total shares outstanding is 73.76%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Haemonetics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Haemonetics's Institutional Ownership is 69.02%.

STU:HAZ
83GF Score
Haemonetics Corp STU:HAZ
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Haemonetics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Haemonetics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=33.52/45.45
=73.76%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 73.76% mean?
Haemonetics (STU:HAZ) has a Float Percentage Of Total Shares Outstanding of 73.76% as of Jul. 09, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Haemonetics and its competitors.
Is Haemonetics' Float Percentage Of Total Shares Outstanding too high?
Haemonetics' current Float Percentage Of Total Shares Outstanding is 73.76%. Overall, Haemonetics has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Haemonetics' Float Percentage Of Total Shares Outstanding compare to ITGR and IRTC?
Haemonetics' Float Percentage Of Total Shares Outstanding of 73.76% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Medical Devices & Instruments company?
A good Float Percentage Of Total Shares Outstanding depends on the Medical Devices & Instruments industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Haemonetics and its competitors. Haemonetics's current Float Percentage Of Total Shares Outstanding is 73.76%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haemonetics stock overvalued right now?
Haemonetics (STU:HAZ) has a current Float Percentage Of Total Shares Outstanding of 73.76%. The stock's GF Value™ is €74.31, compared to a current price of €64.50 — trading 13.2% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 73.76%. Haemonetics' overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Haemonetics (STU:HAZ), the current Float Percentage Of Total Shares Outstanding is 73.76% as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Haemonetics (STU:HAZ) Overvalued in 2026?

Based on GuruFocus' analysis, Haemonetics stock appears to be undervalued. The current stock price of €64.50 is trading 13.2% below its estimated GF Value™ of €74.31.

Key valuation signals for STU:HAZ:

  • Float Percentage Of Total Shares Outstanding: 73.76%
  • GF Value™: €74.31 vs. price of €64.50 (13.2% below fair value)
  • GF Score™: 83/100 with 4 warning signs

No single metric tells the full story. See the STU:HAZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Haemonetics Business Description

Other Exchanges HAE:USA
Address 125 Summer Street, Boston, MA, USA, 02110
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
83GF Score

Get the complete analysis for STU:HAZ

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€64.50
Price
€74.31
GF Value